Prenetics Global Limited (PRE), a health sciences company, has undergone a significant rebuilding phase in recent years and anticipates 2025 to be a pivotal year in its continued transformation.
The company operates across three strategic segments, namely: Consumer Health, Prevention, and Diagnostics, each operated through dedicated business units.
IM8 Health, a new health and wellness brand, and Europa Sports Partners, a sports distribution company, operate under the Consumer Health segment. CircleDNA, the company's flagship consumer genetic testing brand, is part of the Prevention segment, while ACT Genomics, which has achieved FDA clearance for comprehensive genomic profiling of solid tumors, falls under the Diagnostics segment. In addition, the company holds a 35% stake in Insighta, an early cancer detection company developing a non-invasive, multi-cancer screening platform.
For comments and feedback contact: editorial@rttnews.com
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.